eOncology Report

Summer 2011

ASCO: CT lung screenings show a benefit

Suspicious findings were three times greater with CT scans than with chest X-rays in a large national study.
[ Rachel Sanborn, M.D., co-medical director, Providence Thoracic Oncology Program ]

ASCO: Combo study brings mixed results

A trial testing apricoxib with erlotinib showed longer survival in younger patients with metastatic lung cancer, but failed to meet its goal.
[ Rachel Sanborn, M.D., co-medical director, Providence Thoracic Oncology Program ]

The promise of statins as a chemopreventive

A clinical trial examines whether statins will inhibit a recurrence in patients with resected stage I or II colorectal cancer.
[ Anupama Kurup, M.D., medical oncologist, Providence Oncology and Hematology Care Clinic ]

Multidisciplinary cancer clinics grow

Providence Cancer Center’s one-stop clinics now cover lung cancer, gynecologic cancers, dysplasia, survivorship and palliative care.
[ Lyn Glenn, M.N., F.N.P., A.O.C.N., director, Cancer Clinical Programs ]

“Survivorship and Quality of Life”

Researcher, social worker and cancer survivor Brad Zebrack, Ph.D., discusses how professionals can help the growing number of U.S. cancer survivors. Registration required.

Providence researchers earn national grants

Researchers Michael Gough, Ph.D., and Andrew Weinberg, Ph.D., have received $450,000 and $935,000 respectively to study immunotherapies that will treat metastatic breast cancer and prostate cancer.

After treatment: the medicine of survivorship

Providence Cancer Survivor Clinic provides treatment plans for patients dealing with the lingering physical and psychological legacies of cancer.
[ Jennifer Weprin, M.S.N., F.N.P.-B.C., nurse practitioner, Providence Cancer Survivor Clinic ]

Who’s publishing and presenting

Providence Cancer Center’s oncologists, surgeons and researchers are traveling the country and sometimes the globe to share their expertise.

Photo gallery: Providence Cancer Center luncheon

The annual event continues to draw a packed house. Biblical scholar and prostate cancer survivor John R. Kohlenberger III was this year’s keynote speaker.

Register now: Head and neck conference

“Technological Advances in Head and Neck Oncology and Craniomaxillofacial Surgery” in Portland July 22-24


Copyright © 2021 Providence Health & Services. All rights reserved.
Clinical Trials | Quality and Outcomes | News and Events | About Us | Contact Us | Make a Referral